-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
Open Access
- 26 September 2012
- journal article
- review article
- Published by Hindawi Limited in International Journal of Alzheimer's Disease
- Vol. 2012, 1-9
Abstract
Dementia with Lewy bodies (DLB) is a common subtype of dementia in the elderly. DLB is neuropathologically characterized by the presence of Lewy bodies and Lewy neurites, both of which are composed ofα-synuclein. Althoughα-synuclein was initially considered to be an exclusively intracellular protein, it has been found to be secreted into biological fluids.α-Synuclein in biological fluids such as cerebrospinal fluid (CSF) and blood has been discussed as a potential biomarker of DLB andα-synuclein-related disorders, becauseα-synuclein is characteristically accumulated in the brain of patients with these disorders. Theα-synuclein level in CSF has been examined by several investigators, and the majority of studies have shown a reduction in CSFα-synuclein level in DLB andα-synuclein-related disorders. Discrepant findings of studies of plasmaα-synuclein level in patients with DLB have been reported. Because the level ofα-synuclein stored in red blood cells is considerably high, blood contamination and haemolysis during sample collection and processing should be considered as a confounding factor for quantification ofα-synuclein. Here, the recent progress in the studies ofα-synuclein as a biomarker of DLB and their potential clinical applications are reviewed.Keywords
This publication has 64 references indexed in Scilit:
- α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous systemJournal of Neural Transmission, 2012
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodiesNeurobiology of Disease, 2012
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative diseaseIntegrative Biology, 2011
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic functionNeurobiology of Aging, 2011
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionAnnals of Neurology, 2010
- Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseNeuroscience Letters, 2010
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s diseaseBrain, 2010
- Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synucleinProceedings of the National Academy of Sciences, 2009
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000